Abstract
Metastasis is responsible for most deaths of cancer burdens. Given that metastatic cancer cells are generally very low in quantity but high in multiplicity, and able to migrate to diverse organs, the diagnosis and intervention of metastatic cancers face varieties of challenges. For example, the biomarker for early diagnosis, and detection of circulating tumor cells by way of epithelial cell adhesion molecule, are complicated by the epithelial-mesenchymal-transition (EMT). Enhanced permeation and retention have been widely explored but with limitations, especially for microscale metastatic tumors. Furthermore, drug-resistance and side-effects of chemotherapy remain problematic for diverse cancers. Interfaces of cells play essential roles in many physiological activities including signal transduction and immunological recognition, which can be exploited for medical application of interfacial materials; indeed, given unique chemical and physical interfacial properties, numerous micro/nano particles and interfacial materials exhibit great potentials for diagnosis and intervention of metastatic cancers. Here we highlight current research, opportunities and challenges for application potentials of biological interfacial engineering in diagnosis and intervention of metastatic cancers.
Keywords: Biological interfacial engineering, cancer, cancer diagnosis and intervention, metastasis.
Current Medicinal Chemistry
Title:Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention
Volume: 21 Issue: 22
Author(s): B. Wang, H. Zhou, Y. Luo, R. Tang and S. Zheng
Affiliation:
Keywords: Biological interfacial engineering, cancer, cancer diagnosis and intervention, metastasis.
Abstract: Metastasis is responsible for most deaths of cancer burdens. Given that metastatic cancer cells are generally very low in quantity but high in multiplicity, and able to migrate to diverse organs, the diagnosis and intervention of metastatic cancers face varieties of challenges. For example, the biomarker for early diagnosis, and detection of circulating tumor cells by way of epithelial cell adhesion molecule, are complicated by the epithelial-mesenchymal-transition (EMT). Enhanced permeation and retention have been widely explored but with limitations, especially for microscale metastatic tumors. Furthermore, drug-resistance and side-effects of chemotherapy remain problematic for diverse cancers. Interfaces of cells play essential roles in many physiological activities including signal transduction and immunological recognition, which can be exploited for medical application of interfacial materials; indeed, given unique chemical and physical interfacial properties, numerous micro/nano particles and interfacial materials exhibit great potentials for diagnosis and intervention of metastatic cancers. Here we highlight current research, opportunities and challenges for application potentials of biological interfacial engineering in diagnosis and intervention of metastatic cancers.
Export Options
About this article
Cite this article as:
Wang B., Zhou H., Luo Y., Tang R. and Zheng S., Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention, Current Medicinal Chemistry 2014; 21 (22) . https://dx.doi.org/10.2174/0929867321666131213102724
DOI https://dx.doi.org/10.2174/0929867321666131213102724 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Important Role of Oncolytic Viruses in Common Cancer Treatments
Current Cancer Therapy Reviews Preparation, Pharmacokinetic and Application of Gold Nanoclusters (AuNCs) in Tumor Treatment
Current Medicinal Chemistry Recent Advances in the Imaging of Programmed Cell Death
Current Pharmaceutical Design Small Molecule Fluorescent Ligands as Central Nervous System Imaging Probes
Mini-Reviews in Medicinal Chemistry Thrombospondin and Apoptosis: Molecular Mechanisms and Use for Design of Complementation Treatments
Current Drug Targets Perspective of MiRNAs in Clinical Glioblastoma Research
Current Signal Transduction Therapy Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Nucleic Acid Carrier Systems Based on Polyethylenimine Conjugates for the Treatment of Metastatic Tumors
Current Medicinal Chemistry Inducible Nitric Oxide Synthase-Vascular Endothelial Growth Factor Axis: A Potential Target to Inhibit Tumor Angiogenesis by Dietary Agents
Current Cancer Drug Targets Flavonoids as Anticancer Agents: Recent Progress and State of the Art?
Current Organic Chemistry The Endocannabinoid System in Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Better Targeting Melanoma: Options Beyond Surgery and Conventional Chemotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer
Current Chemical Biology Recent Developments in Boron Neutron Capture Therapy (BNCT) Driven by Nanotechnology
Current Chemical Biology Chemistry of Tumour Targeted T1 Based MRI Contrast Agents
Current Topics in Medicinal Chemistry Nuclear Magnetic Resonance Spectroscopy of Lipids in Cancer
Current Organic Chemistry Is the Clinical Use of Cannabis by Oncology Patients Advisable?
Current Medicinal Chemistry Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Current Drug Targets Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability
Anti-Cancer Agents in Medicinal Chemistry Targeting Inhibitor of Apoptosis Proteins (IAPs) for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry